If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

13 Aug 2015 14:00

RNS Number : 0084W
Subex Limited
13 August 2015
 

 

 

 

 

August 13, 2015

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

Dear Sirs,

Sub: Outcome of the Board Meeting held on August 12, 2015

Please be informed that the following important items were discussed and approved at the Board Meeting held on August 12, 2015

Ø Approval of the unaudited standalone and consolidated Financial Results of the Company for the quarter ended June 30, 2015

Ø Re-appointment of Mr. Surjeet Singh as the Managing Director & CEO of the Company, for a period of one year from October 5, 2015 to hold office until October 4, 2016 as per the terms of appointment.

 

 Please find hereto enclosed consolidated Financial Results of the Company.  

We request you to take the aforesaid notification on record.

Yours faithfully

For and on behalf of Subex Limited

 

 

Ganesh K V

Chief Financial Officer, Global Head -Legal and Company Secretary

 

SUBEX LTD

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

Statement of Consolidated Unaudited Results for the Quarter Ended June 30 2015

PART - I (Rs in Lakhs unless otherwise stated)

 

 

 

 

 

 

 

1

 

 

 

 

 

2 (a) (b) (c) (d) (e)

 

 

3

 

 

4

 

5

 

6 (a) (b) (c)

 

7

 

 

8

 

9

 

 

 

Particulars

Consolidated

 

3 months ended

Preceding 3 months ended

Corresponding

3 months ended

 

Previous year ended

June 30, 2015

March 31, 2015

June 30, 2014

March 31, 2015

Unaudited

Audited

(refer note 7)

Unaudited

Audited

Income from operations

Net sales/ income from operations

 

7,351

 

11,216

 

6,518

 

35,983

Total income from operations (net)

7,351

11,216

6,518

35,983

 

Expenses

Cost of hardware, software and support charges Employee benefits expense and sub-contract charges Other expenditure

Depreciation and amortisation expense

Exchange fluctuation loss (net)

 

 

125

4,534

1,654

102

1,176

 

 

1,237

3,434

2,578

93

812

 

 

131

4,206

1,792

122

733

 

 

2,093

16,376

8,256

402

1,250

Total expenses

7,591

8,154

6,984

28,377

(Loss)/Profit from operations before other income, finance costs and

tax (1-2)

(240)

3,062

(466)

7,606

 

Other income

 

33

 

60

 

31

 

97

(Loss)/Profit from ordinary activities before finance costs and tax (3+4)

(207)

3,122

(435)

7,703

Finance costs

Interest on FCCBs (refer note 3(b) & 3(c)) Interest on term loan

Other finance costs

 

(475)

231

312

 

839

219

435

 

846

197

515

 

3,352

850

1,902

(Loss)/Profit from ordinary activities after finance costs before tax (5-6)

(275)

1,629

(1,993)

1,599

 

Tax expense (net)

 

200

 

187

 

67

 

578

Net (Loss)/Profit for the period/year (7-8)

(475)

1,442

(2,060)

1,021

 

 

 

Particulars

 

3 months ended

Preceding 3 months ended

Corresponding

3 months ended

 

Previous year ended

June 30, 2015

March 31, 2015

June 30, 2014

March 31, 2015

Unaudited

Audited

Unaudited

Audited

10

 

11

Paid up share capital

- Equity (face value of Rs. 10/-)

Reserves excluding revaluation reserves as per balance sheet of previous accounting year

 

19,891

 

-

 

18,292

 

2,612

 

16,910

 

-

 

18,292

 

2,612

12

(Loss)/Earnings per share (of Rs. 10/- each) (not annualised in case of the

interim periods):

- Basic

- Diluted

 

 

(0.24) (0.24)

 

 

 

0.84

0.84

 

 

 

(1.22) (1.22)

 

 

 

0.59

0.59

PART - II

 

 

 

A

1

 

 

 

 

2

 

3 months ended

June 30, 2015

Preceding 3 months ended March 31, 2015

Corresponding

3 months ended

June 30, 2014

 

Previous year ended

March 31, 2015

PARTICULARS OF SHAREHOLDING

Public shareholding:*

- Number of shares (refer note 3(e))

- Percentage of holding (to total shareholding)

 

Promoters and promoter group shareholding(refer note 6)

a) Pledged/Encumbered

- Number of shares

- Percentage of shares (as a % of the total shareholding of promoter and promoter group)

- Percentage of shares (as a% of the total share capital of the company)

 

b) Non-encumbered

- Number of shares

- Percentage of shares (as a% of the total shareholding of promoter and promoter group)

- Percentage of shares (as a % of the total share capital of the company)

* Total public shareholding as defined under clause 40A of the listing agreement (excludes underlying shares for GDRs)

 

Global Depository Reciepts

- Number of underlying equity shares

- Percentage of share holding

 

 

197,692,784

99.39%

 

 

 

 

974,044

 

100.00%

 

0.49%

 

 

-

 

0.00%

0.00%

 

 

 

 

 

243,207

0.12%

 

 

180,106,578

99.33%

 

 

 

 

974,044

 

100.00%

 

0.54%

 

 

-

 

0.00%

0.00%

 

 

 

 

 

243,207

0.13%

 

 

162,382,320

96.03%

 

 

 

 

4,974,044

 

76.83%

 

2.94%

 

 

1,500,000

 

23.17%

0.89%

 

 

 

 

 

243,207

0.14%

 

 

180,106,578

99.33%

 

 

 

 

974,044

 

100.00%

 

0.54%

 

 

-

 

0.00%

0.00%

 

 

 

 

 

243,207

0.13%

 

B

INVESTOR COMPLAINTS

 

Particulars

3 Months ended

June 30, 2015

Pending at the beginning of the quarter

Received during the quarter

Disposed off during the quarter

Remaining unresolved at the end of the quarter

Nil Nil Nil Nil

Notes:

1

2

 

 

 

 

 

 

 

3

The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on August 12, 2015.

The Financial Results of Subex Limited (Standalone Information):

 

Particulars

 

3 months ended

Preceding 3 months ended

Corresponding

3 months ended

 

Previous year ended

June 30, 2015

March 31, 2015

June 30, 2014

March 31, 2015

Net sales/ income from operations

6,430

9,526

5,442

30,567

Profit/(Loss) from ordinary activities before tax

447

271

(2,020)

(2,685)

Profit/(Loss) from ordinary activities after tax

397

221

(2,029)

(2,840)

(a) Pursuant to the approval of the holders of "US$ 180 Million 2% convertible unsecured bonds", [of which US$ 39 Million was outstanding ("FCCBs I")] and

"US$ 98.7 Million 5% convertible unsecured bonds", [of which US$ 54.8 Million was outstanding ("FCCBs II")], at their respective meetings held on July 05,

2012 and exchange offers received under the exchange offer memorandum dated June 13, 2012, holders of US$ 38 Million out of FCCBs I and US$ 53.4 Million out of FCCBs II offered their bonds for exchange. Consequently, secured bonds with a face value of US$ 127.721 Million ("FCCBs III") were issued with maturity date of July 07, 2017, having an interest rate of 5.70% p.a. payable semi- annually, an exchange rate for conversion of Rs. 56.05/US$ and an equity conversion price of Rs.22.79 per equity share. In accordance with the terms of FCCBs III, principal amount of US$ 36.321 Million were mandatorily converted into equity shares at the aforesaid conversion price on July 07, 2012. Further, pursuant to the approval of the Reserve Bank of India dated April 27, 2012 and requisite approvals of the bond holders, the maturity period of the un-exchanged portion of FCCBs I of US$ 1 Million and FCCBs II of US$ 1.4 Million stands extended to March 09, 2017, with its other terms and conditions remaining unchanged.

(b) The bond holders in their respective meetings have approved the deferral of aggregate interest of US$ 12.85 Million (Rs. 8180.23 Lakhs) in respect of FCCBs III for the period July 6, 2012 to January 5, 2016 till redemption date of the bonds, being July 07, 2017. Accordingly, interest on FCCBs III included under finance costs in the above results is due for payment on July 07, 2017.

(c) Interest on FCCBs is net off interest accrued but not due amounting to Rs. 1182.06 lakhs in relation to FCCBs III which has been written back during the quarter as the same is considered no longer payable due to the conversion of such FCCBs III with a face value of US$ 16.37 Million into equity shares of the Company during the period September 2012 to June 2015.

(d) The Board in its meeting held on May 14, 2015 approved the reset of conversion price of the FCCBs III which are convertible into equity shares of the Company, from Rs. 22.79 to Rs.13.00 per equity share. Subsequently, the reset of the conversion price has been approved by the shareholders in the annual general meeting held on June 19, 2015 and the bondholders in their meeting held on August 5, 2015. As a result of the aforesaid reset of conversion price, the said bonds with outstanding face value of US $ 75.03 Million would potentially be converted into 323,520,703 equity shares at an exchange rate of Rs. 56.05 with a conversion price of Rs.13 per equity share.

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

5

 

6

 

7

 

 

8

 

 

 

 

 

 

 

 

9

 

 

10

(e) The face value of FCCBs outstanding as on June 30, 2015 are as follows :

Particulars

US$ Million

Rs. in Lakhs

FCCB I

1.00

636.45

FCCB II

1.40

891.03

FCCB III

75.03

47,752.84

Total

77.43

49,280.32

Of the outstanding FCCBs III of US$ 91.4 Million, during the financial years 2012-13, 2014-15 and the quarter ended June 30, 2015, FCCBs III with a face value of US$ 3.25 Million, US$ 6.62 Million and US$ 6.5 Million respectively, were converted at an exchange rate of Rs. 56.05/US$ and an equity conversion price of `

Rs.22.79 resulting in issuance of 7,993,931, 16,282,613 and 15,987,461 equity shares, respectively. With regard to conversion of 1,598,745 equity shares during the quarter and year ended March 31, 2015 as the conversion was recorded by the registrar on April 10, 2015, it has not been included in part II ( Particulars of shareholding) above.

During the financial year ended March 31, 2015, the Company had assessed the carrying value of goodwill arising from its investment in its subsidiary viz. Subex Americas Inc., amounting to Rs.18,606 Lakhs. Based on the management's assessment, there was no impairment of such goodwill taking into account the future operational plans and cash flows as prepared by the management and accordingly, no impairment loss was required to be recognised. There is no change in management's assessment as regards aforementioned carrying value of goodwill as at June 30, 2015. This is an 'Emphasis of Matter' in the Limited Review Report of the Statutory Auditors on the Unaudited Consolidated results.

 

The Company has only single business segment with respect to software products and related services and hence has not made any additional segment disclosures.

Details of Promoters and promoter group shareholding are as per reports furnished by the Registrar and Transfer Agents of the Company.

 

The figures for the quarter ended March 31, 2015 are the balancing figures between audited figures for the year ended March 31, 2015 and unaudited figures for the nine months ended December 31, 2014.

 

Pursuant to the approval of the Board of Directors, the Company has discontinued the operations of two of its subsidiaries with effect from April 01, 2013. The details of unaudited/audited results of the discontinued business consolidated in the above results are as follows:

 

Particulars

 

3 months ended

Preceding 3 months ended

Corresponding

3 months ended

 

Previous year ended

June 30, 2015

March 31, 2015

June 30, 2014

March 31, 2015

Total Income

-

-

-

-

(Loss)/Profit before tax

(0.90)

(420.91)

78.74

(474.18)

(Loss)/Profit after tax

(0.91)

(426.25)

78.70

(479.80)

The figures of the previous period upto March 31, 2015 were audited/ reviewed by a firm of Chartered Accountants other than S.R. Batliboi & Associates LLP. Previous period/year figures have been regrouped/ reclassified, wherever necessary to confirm to current period's classification.

 

Pursuant to clause 41 of the Listing Agreement, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

By Order of the Board

 

Mumbai

Date: August 12, 2015 Sanjeev Aga

Director

For further details on the results, please visit our website: www.subex.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFPKNDPBBKDAFD
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.